2021 Virtual Programme
2022 programme will be confirmed later in the year
The ALPS Meeting Virtual programme has been awarded a total of 4 CPD / CME points by the ASGBI, 2 points for each day.
Pancreas Programme
Thursday 4th February 18:00 GMT / 19:00 CET
|
Speaker | Presentation |
Chris Wolfgang | Neoadjuvant therapy for pancreatic cancer | |
Caroline Verbeke | Pathology examination of pancreatic cancer following neoadjuvant treatment: challenges and opportunities | |
Martijn Meijerink | The role of IRE in pancreatic ductal adenocarcinoma | |
Marco del Chiaro | An update on the management of cystic lesions in the pancreas | |
PANEL | Panel discussion | |
Lotte Boxhoorn | Abstract: Postponed or immediate drainage of infected necrotizing pancreatitis (POINTER): A multicentre randomised trial | |
Lynn Nooijen | Abstract: Outcomes of additional resection of intraoperative positive bile duct margins in perihilar cholangiocarcinoma, a multicentre retrospective matched case-control study | |
Mike Grocott | Everest-07 to COVID-19 | |
Liver Programme
Friday 5th February 18:00 GMT / 19:00 CET |
Speaker | Presentation |
Peter Friend | Normothermic liver perfusion | |
Bjørn Edwin | Minimally invasive liver surgery for colorectal liver metastasis | |
Nancy Kemeny | Metastatic colorectal cancer – Hepatic Arterial Infusion (HAI) therapy | |
Peter Kingham | Microwave and IRE ablations for colorectal cancer liver metastases | |
PANEL | Panel discussion | |
Jan Heil | Abstract: Simultaneous portal and hepatic vein embolisation achieves higher resectability than portal vein embolisation in patients with small liver remnants – Analysis of the DRAGON COLLABORATIVE GROUP | |
Burak Görgec | Abstract: Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-medium volume centres | |
David Tuveson | Skiing around COVID19 to fight pancreatic cancer |